Search results

7 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Located in Newsroom / UNC Lineberger in the News
A Complete Team
Nearly a year ago, thirteen-year-old Liam Canard, of Raleigh, was diagnosed with Hodgkin’s lymphoma. Although his fight against the disease goes on today, he has already won by continuing to do what he loves.
Located in News
UNC Lineberger launches innovative cellular immunotherapy program
UNC Lineberger, with its U.S. FDA-approved Good Manufacturing Practices, or “clean,” facility, is one of only a select academic centers in the United States with the capability to genetically modify patient immune cells for clinical use. This makes it possible for people who live in the Southeastern U.S. to stay closer to home to undergo cellular immunotherapy treatment.
Located in News
Christopher Dittus
Christopher Dittus, DO, MPH, is a UNC Lineberger Comprehensive Cancer Center member, Assistant Professor of Medicine in the Division of Hematology/Oncology at UNC-Chapel Hill School of Medicine.
Located in People / Profiles
Former patient donates $10 million to further blood cancer research at UNC Lineberger
Etteinne “ET” and W. G. Champion “Champ” Mitchell of New Bern, North Carolina, will create a new fund supporting ground-breaking research in blood cancer at UNC Lineberger Comprehensive Cancer Center, including lymphoma, leukemia and myeloma research, in gratitude for the care Champ received and to bolster research directed at finding cures.
Located in News
The thrill of discovery
UNC Lineberger researcher Ben Major, PhD, an assistant professor in the UNC School of Medicine Department of Cell Biology and Physiology, studies cell signaling pathways in normal and cancerous cells. He hopes that a finding made by his team earlier this year could lead to a new treatment for a typically fast-growing type of lymphoma.
Located in News
UNC Lineberger lymphoma conference draws experts from North Carolina and Virginia
A range of specialties, including oncology, pathology, nursing and pharmacy, represented at meeting developed to promote discussions about lymphoma cases, share insights and plan ways to collaborate more effectively in regional, multicenter clinical trials.
Located in News